Direct transcriptional up-regulation of cyclooxygenase-2 by hypoxia-inducible factor (HIF)-1 promotes colorectal tumor cell survival and enhances HIF-1 transcriptional activity during hypoxia
Abstract
Cyclooxygenase (COX)-2, the inducible key enzyme for prostanoid biosynthesis, is overexpressed in most colorectal carcinomas and a subset of colorectal adenomas. Genetic, biochemical, and clinical evidence indicates an important role for COX-2 in colorectal tumorigenesis. Although COX-2 can be induced by aberrant growth factor signaling and oncogene activation during colorectal tumorigenesis, the role of microenvironmental factors such as hypoxia in COX-2 regulation remains to be elucidated. For the first time, we report that under hypoxic conditions COX-2 protein levels increase in colorectal adenoma and carcinoma cells. Rigorous analyses reveal that COX-2 up-regulation is transcriptional and is associated with hypoxia-inducible factor (HIF)-1alpha induction. Oligonucleotide pull-down and chromatin immunoprecipitation assays reveal that HIF-1alpha binds a hypoxia-responsive element on the COX-2 promoter. COX-2 up-regulation during hypoxia is accompanied by increased levels of prostaglandin E(2) (PGE(2)), which promote tumor cell survival under hypoxic conditions. In addition, elevated levels of PGE(2) in hypoxic colorectal tumor cells enhance vascular endothelial growth factor expression and HIF-1 transcriptional activity by activating the mitogen-activated protein kinase pathway, showing a potential positive feedback loop that contributes to COX-2 up-regulation during hypoxia. This study identifies COX-2 as a direct target for HIF-1 in colorectal tumor cells. In addition, COX-2 up-regulation represents a pivotal cellular adaptive response to hypoxia with implication for colorectal tumor cell survival and angiogenesis. We propose that using modified COX-2-selective inhibitors, which are only activated under hypoxic conditions, could potentially be a novel more selective strategy for colorectal cancer prevention and treatment.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Hypoxia induces COX-2.
“In addition, hypoxia also induces COX-2 [86].”
From The Pathogenesis of Adenomyosis vis-à-vis Endometriosis (2020) · cites this paper as [86]
Cites
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885 · see citing works
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717 · see citing works
Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212 · see citing works
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535 · see citing works
Hypoxia — a key regulatory factor in tumour growth
Harris, A. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc704 · Cited by 5,177 · see citing works
Lessons from hereditary colorectal cancer
Kinzler, K. W., & Vogelstein, B. (1996) · Cell · doi:10.1016/s0092-8674(00)81333-1 · Cited by 4,919 · see citing works
The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous Polyposis
Steinbach, G., Lynch, P. M., Phillips, R. K. S., Wallace, M. H., Hawk, E. T., Gordon, G., Wakabayashi, N., Saunders, B. P., Shen, Y., Fujimura, T., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006293422603 · Cited by 2,522 · see citing works
Regulation of angiogenesis by hypoxia: role of the HIF system
Pugh, C. W., & Ratcliffe, P. J. (2003) · Nature Medicine · doi:10.1038/nm0603-677 · Cited by 2,520 · see citing works
Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas
Eberhart, C. E., Coffey, R. J., Aramandla, R., Giardiello, F. M., Ferrenbach, S., & DuBois, R. N. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90246-1 · Cited by 2,512 · see citing works
Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
Carmeliet, P., Dor, Y., Herbert, J.-M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P., et al. (1998) · Nature · doi:10.1038/28867 · Cited by 2,502 · see citing works
Oshima, M., Dinchuk, J. E., Kargman, S., Oshima, H., Hancock, B. C., Kwong, E. C., Trzăskos, J. M., Evans, J. F., & Taketo, M. M. (1996) · Cell · doi:10.1016/s0092-8674(00)81988-1 · Cited by 2,363 · see citing works
Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours
Graeber, T. G., Osmanian, C., Jacks, T., Housman, D. E., Koch, C. J., Lowe, S. W., & Giaccia, A. J. (1996) · Nature · doi:10.1038/379088a0 · Cited by 2,300 · see citing works
Cyclooxygenase regulates angiogenesis induced by colon cancer cells
Tsujii, M., Kawano, S., Tsuji, S., Sawaoka, H., Hori, M., & DuBois, R. N. (1998) · Cell · doi:10.1016/s0092-8674(00)81433-6 · Cited by 2,272 · see citing works
(1999) · PubMed · Cited by 2,204 · see citing works
Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells.
Sheng, H., Shao, J., Morrow, J. D., Beauchamp, R. D., & Dubois, R. N. (1998) · PubMed · Cited by 1,114 · see citing works
Maxwell, P. H., Dachs, G. U., Gleadle, J. M., Nicholls, L. G., Harris, A. L., Stratford, I. J., Hankinson, O., Pugh, C. W., & Ratcliffe, P. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.15.8104 · Cited by 1,084 · see citing works
Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2
Gupta, R. A., & DuBois, R. N. (2001) · Nature reviews. Cancer · doi:10.1038/35094017 · Cited by 1,067 · see citing works
HIF-1 and tumor progression: pathophysiology and therapeutics
Semenza, G. L. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02317-1 · Cited by 1,060 · see citing works
Masson, N., Willam, C., Maxwell, P. H., Pugh, C. W., & Ratcliffe, P. J. (2001) · The EMBO Journal · doi:10.1093/emboj/20.18.5197 · Cited by 1,014 · see citing works
Wang, D. (2005) · Gut · doi:10.1136/gut.2004.047100 · Cited by 906 · see citing works
Signal transduction to hypoxia-inducible factor 1
Semenza, G. L. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01168-1 · Cited by 860 · see citing works
An essential role for p300/CBP in the cellular response to hypoxia
Arany, Z., Huang, L. E., Eckner, R., Bhattacharya, S., Jiang, C., Goldberg, M. A., Bunn, H. F., & Livingston, D. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.23.12969 · Cited by 790 · see citing works
Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2.
Sheng, H., Shao, J., Kirkland, S. C., Isakson, P. C., Coffey, R. J., Morrow, J. D., Beauchamp, R. D., & DuBois, R. N. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119400 · Cited by 713 · see citing works
Schmedtje, J. F., Ji, Y.-S., Liu, W. L., DuBois, R. N., & Runge, M. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.1.601 · Cited by 668 · see citing works
Prostaglandin E2 Increases Growth and Motility of Colorectal Carcinoma Cells
Sheng, H., Shao, J., Washington, M. K., & DuBois, R. N. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009689200 · Cited by 654 · see citing works
Hypoxia, Clonal Selection, and the Role of HIF-1 in Tumor Progression
Semenza, G. L. (2000) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409230091169186 · Cited by 651 · see citing works
Transactivation and Inhibitory Domains of Hypoxia-inducible Factor 1α
Jiang, B.-H., Zheng, J. Z., Leung, S. W., Roe, R., & Semenza, G. L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.31.19253 · Cited by 629 · see citing works
COX-2: A Molecular Target for Colorectal Cancer Prevention
Brown, J. R., & DuBois, R. N. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.051 · Cited by 529 · see citing works
Oxygen(es) and the hypoxia-inducible factor-1.
Wenger, R. H., & Gassmann, M. (1997) · PubMed · Cited by 513 · see citing works
YC-1: A Potential Anticancer Drug Targeting Hypoxia-Inducible Factor 1
Yeo, E., Chun, Y., Cho, Y.-S., Kim, J., Lee, J.-C., Kim, M.-S., & Park, J.-W. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.7.516 · Cited by 477 · see citing works
Hypoxia Inhibits G1/S Transition through Regulation of p27 Expression
Gardner, L. B., Li, Q., Park, M. S., Flanagan, W. M., Semenza, G. L., & Dang, C. V. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010189200 · Cited by 390 · see citing works
MAPK Signaling Up-regulates the Activity of Hypoxia-inducible Factors by Its Effects on p300
Sang, N., Stiehl, D. P., Bohensky, J., Leshchinsky, I., Srinivas, V., & Caro, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209702200 · Cited by 370 · see citing works
Elder, D. J. E., Halton, D. E., Hague, A., & Paraskeva, C. (1997) · PubMed · Cited by 366 · see citing works
Chang, S.-H., Liu, C. H., Conway, R. E., Han, D. K. M., Nithipatikom, K., Trifan, O. C., Lane, T. F., & Hla, T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2535911100 · Cited by 361 · see citing works
Tumor hypoxia: A target for selective cancer therapy
Kizaka‐Kondoh, S., Inoue, M., Harada, H., & Hiraoka, M. (2003) · Cancer Science · doi:10.1111/j.1349-7006.2003.tb01395.x · Cited by 353 · see citing works
Fukuda, R., Kelly, B., & Semenza, G. L. (2003) · PubMed · Cited by 293 · see citing works
Regulation of cyclooxygenase-2 expression by the Wnt and ras pathways.
Araki, Y., Okamura, S., Hussain, S. P., Nagashima, M., He, P., Shiseki, M., Miura, K., & Harris, C. C. (2003) · PubMed · Cited by 288 · see citing works
Patients with adenomatous polyps and carcinomas have increased colonic mucosal prostaglandin E2.
Pugh, S., & Thomas, G. A. O. (1994) · Gut · doi:10.1136/gut.35.5.675 · Cited by 266 · see citing works
Bnip3L is induced by p53 under hypoxia, and its knockdown promotes tumor growth
Fei, P., Wang, W., Kim, S.-H., Wang, S., Burns, T. F., Sax, J. K., Buzzai, M., Dicker, D. T., McKenna, W. G., Bernhard, E. J., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.10.012 · Cited by 231 · see citing works
Wang, D., Buchanan, F. G., Wang, H., Dey, S. K., & DuBois, R. N. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3671 · Cited by 193 · see citing works
Chell, S. D., Witherden, I. R., Dobson, R. R., Moorghen, M., Herman, A., Qualtrough, D., Williams, A. C., & Paraskeva, C. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3702 · Cited by 141 · see citing works
Low doses of oral dexamethasone for hormone-refractory prostate carcinoma
Nishimura, K., Nonomura, N., Yasunaga, Y., Takaha, N., Inoue, H., SUGAO, H., Yamaguchi, S., Ukimura, O., Miki, T., & Okuyama, Ä. (2000) · Cancer · doi:10.1002/1097-0142(20001215)89:12 · Cited by 125 · see citing works
Williams, A. C., Harper, S., & Paraskeva, C. (1990) · PubMed · Cited by 121 · see citing works
Regulation of Cyclooxygenase-2 by Hypoxia and Peroxisome Proliferators in the Corneal Epithelium
Bonazzi, A., Mastyugin, V., Mieyal, P. A., Dunn, M. W., & Schwartzman, M. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2837 · Cited by 120 · see citing works
Csiki, I., Yanagisawa, K., Haruki, N., Nadaf, S., Morrow, J. D., Johnson, D. H., & Carbone, D. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1357 · Cited by 96 · see citing works
Patsos, H. A. (2005) · Gut · doi:10.1136/gut.2005.073403 · Cited by 94 · see citing works
Elder, D. J. E., Baker, J. A., Banu, N. A., Moorghen, M., & Paraskeva, C. (2002) · The Journal of Pathology · doi:10.1002/path.1232 · Cited by 81 · see citing works
Crew, T. E. (2000) · Carcinogenesis · doi:10.1093/carcin/21.1.69 · Cited by 74 · see citing works
Nitrate, nitrite and N‐nitroso compounds in human bladder cancer associated with schistosomiasis
Badawi, A. F. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000515)86:4 · Cited by 11 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Greenhough, A., Smartt, H. J. M., Moore, A. E., Roberts, H. R., Williams, A. C., Paraskeva, C., & Kaidi, A. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp014 · Cited by 1,220 · see citing works
The role of COX-2 in intestinal inflammation and colorectal cancer
Wang, D., & DuBois, R. N. (2009) · Oncogene · doi:10.1038/onc.2009.421 · Cited by 893 · see citing works
Conquering the Hypoxia Limitation for Photodynamic Therapy
Wan, Y., Fu, L., Li, C., Lin, J., & Huang, P. (2021) · Advanced Materials · doi:10.1002/adma.202103978 · Cited by 705 · see citing works
Prabhakar, N. R., & Semenza, G. L. (2012) · Physiological Reviews · doi:10.1152/physrev.00030.2011 · Cited by 641 · see citing works
Oxygen-dependent regulation of mitochondrial respiration by hypoxia-inducible factor 1
Semenza, G. L. (2007) · Biochemical Journal · doi:10.1042/bj20070389 · Cited by 541 · see citing works
Interaction between β-catenin and HIF-1 promotes cellular adaptation to hypoxia
Kaidi, A., Williams, A. C., & Paraskeva, C. (2007) · Nature Cell Biology · doi:10.1038/ncb1534 · Cited by 518 · see citing works
Big opportunities for small molecules in immuno-oncology
Adams, J. L., Smothers, J. F., Srinivasan, R., & Hoos, A. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4596 · Cited by 482 · see citing works
Molecular Pathways Involved in Colorectal Cancer: Implications for Disease Behavior and Prevention
Colussi, D., Brandi, G., Bazzoli, F., & Ricciardiello, L. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140816365 · Cited by 429 · see citing works
Metabolic Hallmarks of Tumor and Immune Cells in the Tumor Microenvironment
Renner, K., Singer, K., Koehl, G. E., Geissler, E. K., Peter, K., Siska, P. J., & Kreutz, M. P. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00248 · Cited by 378 · see citing works
Semenza, G. L. (2009) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.69 · Cited by 311 · see citing works
HIF Inhibitors: Status of Current Clinical Development
Fallah, J., & Rini, B. I. (2019) · Current Oncology Reports · doi:10.1007/s11912-019-0752-z · Cited by 308 · see citing works
Masson, N., & Ratcliffe, P. J. (2014) · Cancer & Metabolism · doi:10.1186/2049-3002-2-3 · Cited by 296 · see citing works
Cytokines, Inflammation and Colon Cancer
Klampfer, L. (2011) · Current Cancer Drug Targets · doi:10.2174/156800911795538066 · Cited by 290 · see citing works
HIF1A Overexpression Is Associated with Poor Prognosis in a Cohort of 731 Colorectal Cancers
Baba, Y., Nosho, K., Shima, K., Irahara, N., Chan, A. T., Meyerhardt, J. A., Chung, D. C., Giovannucci, E. L., Fuchs, C. S., & Ogino, S. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090972 · Cited by 284 · see citing works
Role of hypoxia-inducible factors in breast cancer metastasis
Gilkes, D. M., & Semenza, G. L. (2013) · Future Oncology · doi:10.2217/fon.13.92 · Cited by 274 · see citing works
The role of hypoxia‐inducible factor 1 in tumor immune evasion
Li, Y., Wu, W., Wang, X., Fang, L., Adam, V., Nepovimová, E., Wu, Q., & Kuča, K. (2020) · Medicinal Research Reviews · doi:10.1002/med.21771 · Cited by 273 · see citing works
Broekgaarden, M., Weijer, R., van Gulik, T. M., Hamblin, M. R., & Heger, M. (2015) · Cancer and Metastasis Reviews · doi:10.1007/s10555-015-9588-7 · Cited by 261 · see citing works
MiR-101 downregulation is involved in cyclooxygenase-2 overexpression in human colon cancer cells
Strillacci, A., Griffoni, C., Sansone, P., Paterini, P., Piazzi, G., Lazzarini, G., Spisni, E., Pantaleo, M. A., Biasco, G., & Tomasi, V. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.12.010 · Cited by 243 · see citing works
Liang, X., Chen, M., Bhattarai, P., Hameed, S., & Dai, Z. (2020) · ACS Nano · doi:10.1021/acsnano.0c05617 · Cited by 220 · see citing works
IDO Expression in Cancer: Different Compartment, Different Functionality?
Meireson, A., Devos, M., & Brochez, L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.531491 · Cited by 207 · see citing works
Cellular and molecular mechanisms of inflammation‐induced angiogenesis
Szade, A., Grochot‐Przeczek, A., Florczyk, U., Józkowicz, A., & Dulak, J. (2015) · IUBMB Life · doi:10.1002/iub.1358 · Cited by 199 · see citing works
Mechanisms of adaptive angiogenesis to tissue hypoxia
Fong, G. (2008) · Angiogenesis · doi:10.1007/s10456-008-9107-3 · Cited by 201 · see citing works
Bagińska, J., Viry, E., Paggetti, J., Medves, S., Berchem, G., Moussay, E., & Janji, B. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00490 · Cited by 196 · see citing works
Hypoxia Inducible Factor-1–Independent Pathways in Tumor Angiogenesis
Mizukami, Y., Kohgo, Y., & Chung, D. C. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0111 · Cited by 185 · see citing works
Prostaglandin E2 and the EP receptors in malignancy: possible therapeutic targets?
O'Callaghan, G. P., & Houston, A. M. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13331 · Cited by 181 · see citing works
Shah, Y. M., Ito, S., Morimura, K., Chen, C., Yim, S., Haase, V. H., & Gonzalez, F. J. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.009 · Cited by 168 · see citing works
Obesity and colorectal cancer: molecular features of adipose tissue
Martínez‐Useros, J., & García‐Foncillas, J. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-0772-5 · Cited by 169 · see citing works
Paving the Rho in cancer metastasis: Rho GTPases and beyond
Jansen, S. R., Gosens, R., Wieland, T., & Schmidt, M. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.09.002 · Cited by 169 · see citing works
The Pathogenesis of Adenomyosis vis-à-vis Endometriosis
Guo, S.-W. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020485 · Cited by 165 · see citing works
“Lastly, many genes, such as ERβ and cyclooxygenase-2 (COX-2), that are involved in tissue repair and inflammation, are upregulated in adenomyosis.”
InfluentialFitzpatrick, S. F., Tambuwala, M. M., Brüning, U., Schaible, B., Scholz, C. C., Byrne, A. T., O’Connor, A. E., Gallagher, W. M., Lenihan, C. R., Garvey, J., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1002256 · Cited by 153 · see citing works
Inflammatory pathways in the early steps of colorectal cancer development
Mariani, F. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i29.9716 · Cited by 156 · see citing works
Greenhough, A., Patsos, H. A., Williams, A. C., & Paraskeva, C. (2007) · International Journal of Cancer · doi:10.1002/ijc.22917 · Cited by 155 · see citing works
Cyclooxygenase-2 in oncogenesis
Rizzo, M. T. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.12.026 · Cited by 153 · see citing works
Goh, J. X. H., Tan, L. T., Goh, J. K., Chan, K., Pusparajah, P., Lee, L., & Goh, B. H. (2019) · Cancers · doi:10.3390/cancers11060867 · Cited by 152 · see citing works
Advances in the Potential Biomarkers of Epilepsy
Kobylarek, D., Iwanowski, P. S., Lewandowska, Z., Limphaibool, N., Szafranek, S., Labrzycka, A., & Kozubski, W. P. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00685 · Cited by 153 · see citing works
Boleij, A., & Tjalsma, H. (2012) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/j.1469-185x.2012.00218.x · Cited by 145 · see citing works
Chell, S. D., Кади, А., Williams, A. C., & Paraskeva, C. (2006) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.05.002 · Cited by 144 · see citing works
The role of hypoxia-inducible factors in cancer
Maynard, M. A., & Ohh, M. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7082-2 · Cited by 138 · see citing works
Mougiakakos, D., Johansson, C. C., Trocmé, E., All‐Ericsson, C., Economou, M. A., Larsson, O., Seregard, S., & Kiessling, R. W. (2010) · Cancer · doi:10.1002/cncr.24999 · Cited by 135 · see citing works
Raja, R., Kale, S., Thorat, D., Soundararajan, G., Lohite, K., Mane, A. D., Karnik, S. V., & Kundu, G. C. (2013) · Oncogene · doi:10.1038/onc.2013.171 · Cited by 132 · see citing works
Kim, S.-H., Park, Y., Kim, S., Lee, J., Wang, D., & DuBois, R. N. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1262 · Cited by 131 · see citing works
Jang, G. Y., Jeon, J. H., Cho, S. Y., Shin, D. M., Kim, C. W., Jeong, E. M., Bae, H.-S., Kim, T. W., Lee, S. H., Choi, Y. H., et al. (2009) · Oncogene · doi:10.1038/onc.2009.342 · Cited by 127 · see citing works
Hypoxia activates the cyclooxygenase-2–prostaglandin E synthase axis
Lee, J. J., Natsuizaka, M., Ohashi, S., Wong, G. S., Takaoka, M., Michaylira, C. Z., Budo, D., Tobias, J. W., Kanai, M., Shirakawa, Y., et al. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp326 · Cited by 123 · see citing works
Bocca, C., Ievolella, M., Autelli, R., Motta, M., Mosso, L., Torchio, B., Bozzo, F., Cannito, S., Paternostro, C., Colombatto, S., et al. (2013) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.860447 · Cited by 119 · see citing works
Hypoxia Activates NF-κB–Dependent Gene Expression Through the Canonical Signaling Pathway
Oliver, K. M., Garvey, J., Ng, C. T., Veale, D. J., Fearon, U., Cummins, E. P., & Taylor, C. T. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2008.2400 · Cited by 120 · see citing works
Strillacci, A., Valerii, M. C., Sansone, P., Caggiano, C., Sgromo, A., Vittori, L., Fiorentino, M., Poggioli, G., Rizzello, F., Campieri, M., et al. (2012) · The Journal of Pathology · doi:10.1002/path.4097 · Cited by 118 · see citing works
Shi, J., Liu, F., ZHANG, W., Liu, X., Lin, B., & Tang, X. (2015) · Oncology Reports · doi:10.3892/or.2015.3889 · Cited by 117 · see citing works
Hypoxia inducible factor-1α: Its role in colorectal carcinogenesis and metastasis
Nagaraju, G. P., Bramhachari, P. V., Raghu, G., & El‐Rayes, B. F. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.06.005 · Cited by 114 · see citing works
He, J., Wang, M., Jiang, Y., Chen, Q., Xu, S., Xu, Q., Jiang, B., & Liu, L.-Z. (2014) · Environmental Health Perspectives · doi:10.1289/ehp.1307545 · Cited by 115 · see citing works
Kim, S., Seong, K.-J., Kim, W.-J., & Jung, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23074004 · Cited by 116 · see citing works
Hypoxia-regulated lncRNAs in cancer
Chang, Y., Zhang, K., Hu, Z., Qi, H.-X., Shi, Z., Han, X., Han, Y., & Wei, H. (2015) · Gene · doi:10.1016/j.gene.2015.08.049 · Cited by 113 · see citing works
Tumor metabolism as modulator of immune response and tumor progression
Gottfried, E., Kreutz, M. P., & Mackensen, A. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.02.009 · Cited by 112 · see citing works
New Insights on COX-2 in Chronic Inflammation Driving Breast Cancer Growth and Metastasis
Hugo, H. J., Saunders, C. M., Ramsay, R. G., & Thompson, E. W. (2015) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-015-9333-4 · Cited by 108 · see citing works
Ahmadi, M., Emery, D. C., & Morgan, D. J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1060 · Cited by 105 · see citing works
Broekgaarden, M., Weijer, R., Krekorian, M., van den IJssel, B., Kos, M., Alles, L. K., van Wijk, A. C. W. A., Bikádi, Z., Hazai, E., van Gulik, T. M., et al. (2016) · Nano Research · doi:10.1007/s12274-016-1059-0 · Cited by 101 · see citing works
Hypoxia and Prostate Cancer Aggressiveness: A Tale With Many Endings
Fraga, A. M., Ribeiro, R. J. T., Príncipe, P., Lopes, C., & Medeiros, R. (2015) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2015.03.006 · Cited by 102 · see citing works
MacFie, T. S., Poulsom, R., Parker, A., Warnes, G., Boitsova, T., Nijhuis, A. M., Suraweera, N., Poehlmann, A., Szary, J., Feakins, R. M., et al. (2014) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000442012.45038.0e · Cited by 101 · see citing works
Mechanistic Aspects of COX-2 Expression in Colorectal Neoplasia
Dixon, D. A., Blanco, F. F., Bruno, A., & Patrignani, P. (2012) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-30331-9_2 · Cited by 99 · see citing works
Hypoxia-inducible factor-1 (HIF-1) promotes LDL and VLDL uptake through inducing VLDLR under hypoxia
Shen, G., Zhao, Y., Chen, M., Zhang, F., Liu, X., Wang, Y., Liu, C., Yu, J., & Zhang, J. (2011) · Biochemical Journal · doi:10.1042/bj20111377 · Cited by 93 · see citing works
Spinella, F., Rosanò, L., Castro, V. D., Decandia, S., Nicotra, M. R., Natali, P. G., & Bagnato, A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2606 · Cited by 92 · see citing works
LncRNA SNHG11 facilitates tumor metastasis by interacting with and stabilizing HIF-1α
Xu, L., Huan, L., Guo, T., Wu, Y., Liu, Y., Wang, Q., Huang, S., Xu, Y., Liang, L., & He, X. (2020) · Oncogene · doi:10.1038/s41388-020-01512-8 · Cited by 90 · see citing works
Oxygen-Independent Stabilization of Hypoxia Inducible Factor (HIF)-1 during RSV Infection
Haeberle, H. A., Dürrstein, C., Rosenberger, P., Hosakote, Y. M., Kuhlicke, J., Kempf, V. A. J., Garofalo, R. P., & Eltzschig, H. K. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003352 · Cited by 89 · see citing works
Stewart, G. D. (1994) · Oncology Reports · doi:10.3892/or_00000180 · Cited by 89 · see citing works
Noordhuis, M. G., Eijsink, J. J. H., Roossink, F., de Graeff, P., Pras, E., Schuuring, E. M. D., Wisman, G. B. A., de Bock, G. H., & van der Zee, A. G. J. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.09.043 · Cited by 89 · see citing works
Targets for protection and mitigation of radiation injury
Khodamoradi, E., Hoseini‐Ghahfarokhi, M., Amini, P., Motevaseli, E., Shabeeb, D., Musa, A. E., Najafi, M., & Farhood, B. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03479-x · Cited by 86 · see citing works
Prostaglandin E2 in the Tumor Microenvironment, a Convoluted Affair Mediated by EP Receptors 2 and 4
Santiso, A., Heinemann, Á., & Kargl, J. (2024) · Pharmacological Reviews · doi:10.1124/pharmrev.123.000901 · Cited by 89 · see citing works
NFκB and HIF display synergistic behaviour during hypoxic inflammation
Brüning, U., Fitzpatrick, S. F., Frank, T. D., Birtwistle, M. R., Taylor, C. T., & Cheong, A. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0876-2 · Cited by 83 · see citing works
Hypoxia‐inducible factor‐1 as a therapeutic target in cancer
Tang, C., & Yu, J. Q. (2012) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12038 · Cited by 80 · see citing works
Hypoxia stimulus: An adaptive immune response during dendritic cell maturation
Rama, I., Brüne, B., Torrás, J., Koehl, R., Cruzado, J. M., Bestard, O., Franquesa, M., Lloberas, N., Weigert, A., Herrero, I., et al. (2008) · Kidney International · doi:10.1038/sj.ki.5002792 · Cited by 79 · see citing works
The role of the tissue omega-6/omega-3 fatty acid ratio in regulating tumor angiogenesis
Kang, J. X., & Liu, A. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-012-9401-9 · Cited by 79 · see citing works
Gómez‐Valenzuela, F., Escobar, E., Pérez‐Tomás, R., & Montecinos, V. P. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.686792 · Cited by 77 · see citing works
Wu, S., Kasim, V., Kano, M. R., Tanaka, S., Ohba, S., Miura, Y., Miyata, K., Liu, X., Matsuhashi, A., Chung, U., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-0366 · Cited by 77 · see citing works
Hsu, H.-H., Chen, M., Day, C. H., Lin, Y.-M., Li, S.-Y., Tu, C., Padma, V. V., Shih, H.-N., Kuo, W., & Huang, C. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i7.1171 · Cited by 75 · see citing works
Xue, X., & Shah, Y. M. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs313 · Cited by 73 · see citing works
Jayaraman, T., Tejero, J., Chen, B. B., Blood, A. B., Frizzell, S., Shapiro, C., Tiso, M., Hood, B. L., Wang, X., Zhao, X., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.271973 · Cited by 73 · see citing works
Ullrich, N., Schröder, A., Jantsch, J., Spanier, G., Proff, P., & Kirschneck, C. (2019) · International Journal of Oral Science · doi:10.1038/s41368-019-0066-x · Cited by 69 · see citing works
Law, P. C., Au-Yeung, K. K. W., Chan, L.-Y., & Ko, J. K.-S. (2012) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-12-160 · Cited by 69 · see citing works
Signaling pathways in intestinal homeostasis and colorectal cancer: KRAS at centre stage
Ternet, C., & Kiel, C. (2021) · Cell Communication and Signaling · doi:10.1186/s12964-021-00712-3 · Cited by 69 · see citing works
Astrocytes propel neurovascular dysfunction during cerebral cavernous malformation lesion formation
Lopez‐Ramirez, M. A., Lai, C. C., Soliman, S. I., Hale, P., Pham, A., Estrada, E. J., McCurdy, S., Girard, R., Verma, R., Moore, T., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci139570 · Cited by 66 · see citing works
Potential Targets for Colorectal Cancer Prevention
Temraz, S. N., Mukherji, D., & Shamseddine, A. I. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140917279 · Cited by 65 · see citing works
Huang, M., Wang, L., Chen, J., Bai, M., Zhou, C., Liu, S., & Lin, Q. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3421 · Cited by 65 · see citing works
HIF-1α in colorectal carcinoma: review of the literature.
Ιωάννου, Μ., Paraskeva, E., Baxevanidou, K., Simos, G., Papamichali, R., Papacharalambous, C., Σαμαρά, Μ., & Koukoulis, G. Κ. (2015) · PubMed · Cited by 64 · see citing works
Tsai, Y.-T., Lo, W., Chen, P., Ko, C., Chuang, J., Kao, T., Yang, W., Chang, K., Hung, C.-Y., Kikkawa, U., et al. (2022) · Journal of Biomedical Science · doi:10.1186/s12929-022-00804-3 · Cited by 63 · see citing works
Hypoxia pathway proteins and their impact on the blood vasculature
Rodriguez, D., Watts, D., Gaete, D., Sormendi, S., & Wielockx, B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179191 · Cited by 62 · see citing works
Jin, F., Yang, R., Yao, W., Wang, D., Zhu, Y., Wang, X., Lu, Y., Wang, Y., Zen, K., & Li, L. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.10.025 · Cited by 61 · see citing works
Aloe-emodin suppresses hypoxia-induced retinal angiogenesis via inhibition of HIF-1α/VEGF pathway
Wu, J., Ke, X., Wang, W., Zhang, H., Ma, N., Fu, W., Zhao, M., Gao, X., Hao, X., & Zhang, Z. (2016) · International Journal of Biological Sciences · doi:10.7150/ijbs.16334 · Cited by 61 · see citing works
MiRNA‐26b regulates the expression of cyclooxygenase‐2 in desferrioxamine‐treated CNE cells
Ji, Y., He, Y., Liu, L., & Zhong, X. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.01.036 · Cited by 60 · see citing works
Mariani, F., Sena, P., Marzona, L., Riccio, M., Fano, R. A., Manni, P., Gregorio, C. D., Pezzi, A., de Leòn, M. P., Monni, S., et al. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.02.001 · Cited by 59 · see citing works
Small molecules as theranostic agents in cancer immunology
Li, J., Valkenburgh, J. S. V., Hong, X., Conti, P. S., Zhang, X., & Chen, K. (2019) · Theranostics · doi:10.7150/thno.37218 · Cited by 60 · see citing works
Contribution of hypoxia inducible factor-1 during viral infections
Reyes, A., Corrales, N., Gálvez, N. M. S., Bueno, S. M., Kalergis, A. M., & González, P. A. (2020) · Virulence · doi:10.1080/21505594.2020.1836904 · Cited by 58 · see citing works
Gandhi, S., & Chandna, S. (2017) · Cancer and Metastasis Reviews · doi:10.1007/s10555-017-9669-x · Cited by 60 · see citing works
Metabolic Control of Epigenetics and Its Role in CD8+ T Cell Differentiation and Function
Yerinde, C., Siegmund, B., Glauben, R., & Weidinger, C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02718 · Cited by 59 · see citing works
Lim, W., Park, C., Shim, M. K., Lee, Y. H., Lee, Y., & Lee, Y. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12491 · Cited by 58 · see citing works
Roy, A., Zhang, M., Saad, Y., & Kolattukudy, P. E. (2013) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00203.2013 · Cited by 58 · see citing works
Muraki, C., Ohga, N., Hida, Y., Nishihara, H., Kato, Y., Tsuchiya, K., Matsuda, K., Totsuka, Y., Shindoh, M., & Hida, K. (2011) · International Journal of Cancer · doi:10.1002/ijc.25976 · Cited by 57 · see citing works
Flannigan, K. L., Agbor, T. A., Motta, J., Ferraz, J. G., Wang, R., Buret, A. G., & Wallace, J. L. (2014) · The FASEB Journal · doi:10.1096/fj.14-266015 · Cited by 57 · see citing works
Wu, J., Xiao, K., Ma, N., Wang, W., Fu, W., Zhang, H., Zhao, M., Gao, X., Hao, X., & Zhang, Z. (2016) · Drug Design Development and Therapy · doi:10.2147/dddt.s114022 · Cited by 57 · see citing works
The Eicosanoids, Redox-Regulated Lipid Mediators in Immunometabolic Disorders
de Araújo, A. C. J., Wheelock, C. E., & Haeggström, J. Z. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7332 · Cited by 57 · see citing works
The Crosstalk of PTGS2 and EGF Signaling Pathways in Colorectal Cancer
Wang, D., Xia, D., & DuBois, R. N. (2011) · Cancers · doi:10.3390/cancers3043894 · Cited by 55 · see citing works
Kim, S.-H., Xia, D., Kim, S.-W., Holla, V. R., Menter, D. G., & DuBois, R. N. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2110 · Cited by 54 · see citing works
- Authors
- Kaidi, A., Qualtrough, D., Williams, A. C., & Paraskeva, C.
- Affiliations
- Cancer Research UK (GB)
- Venue
- Cancer Research
- Published
- 2006-07-01
- Volume
- 66
- Issue
- 13
- Pages
- 6683-6691
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W2008854828
- Cited by
- 300
- References
- 49
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 10 · 2023: 6 · 2022: 13 · 2021: 17 · 2020: 24 · 2019: 18 · 2018: 13 · 2017: 16 · 2016: 17 · 2015: 23 · 2014: 16 · 2013: 19 · 2012: 22
- FWCI
- 7.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- Bristol Research (University of Bristol) (publishedVersion)
- Explore Bristol Research (submittedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology › Inflammatory mediators and NSAID effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- cyclooxygenase-2, hypoxia-inducible factor-1α, colorectal cancer, colorectal adenoma, hypoxia, prostaglandin E2, hypoxia response element, transcriptional regulation, vascular endothelial growth factor, MAPK signaling, tumor cell survival, angiogenesis, COX-2 selective inhibitors, tumor microenvironment
- MeSH terms
- Base Sequence, Cell Survival, Humans, Molecular Sequence Data, Promoter Regions, Genetic, Transcription, Genetic, Colorectal Neoplasms, Dinoprostone, Cell Hypoxia, Up-Regulation, Gene Expression Regulation, Enzymologic, Gene Expression Regulation, Neoplastic, HT29 Cells, MAP Kinase Signaling System, HCT116 Cells, Cell Growth Processes, Cyclooxygenase 2, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
